Press release
Liquid Biopsy Market is projected US$ 3.4 Billion by 2024
liquid-biopsy-market-products-application-regions-companies
https://www.renub.com/liquid-biopsy-market-p.php
Get Free Customization in This Report
Liquid Biopsy Market is projected to exceed US$ 3.4 Billion by the year 2024, witnessing the worldwide increasing prevalence of cancer and raising awareness regarding the minimal invasive liquid biopsy technology across the world. Today, liquid biopsy has paved the road of cancer diagnosis and treatment by offering a complete treatment response in real time without the need of serial traditional (solid-tissue) biopsies.
Today, the population across the globe is growing and aging and so is the global burden of cancer; it is estimated that by the year 2030, the global cancer burden will reach nearly 21.7 Million new cancer cases and be around 13 Million cancer deaths. It is also expected that the low and middle income countries accounts for 60% of the cancer deaths due to the lack of medical resources and proper healthcare systems.
Request a free sample copy of the report:
https://www.renub.com/contactus.php
The cases of cancer increases very rapidly around the world owing to the adoption of unhealthy lifestyles and behaviors such as smoking, poor diet, physical inactivity etc. These rising cases of cancer will drive the liquid biopsy market to thrive in the coming years. As liquid biopsy is a simple and non-invasive technique it enables physicians to discover a range of information about patient’s tumor and provide clues about the treatment that a patient’s needs.
Renub Research report titled “Liquid Biopsy Market, by Cancer (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer & Others), Product (Kits & Consumables, Instruments and Services), Circulating Biomarkers (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA) & Exosomes), Sample (Plasma/Serum, Urine & Others), Clinical Application (Monitoring, Prognosis, Theranostics & Screening), Regions (North America, Europe, Asia-Pacific, Latin America and Middle East/Africa), Companies (Thermo Fisher Scientific Inc., Roche Diagnostics, Bio-Rad Laboratories Inc., Biocept Inc., Biocartis, Myriad Genetics Inc., Genomic Health, NeoGenomics Laboratories, Qiagen)” provides a complete analysis of Global Liquid Biopsy Market.
By Cancer – Lung Cancer Controls the Liquid Biopsy Market
The report studies the market of the following cancer segments: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer & Others. Lung cancer and Breast cancer together accounts for the considerable market share in the global liquid biopsy market.
By Product – Majority of Liquid Biopsy Market held by Kits & Consumables
The report studies the market of the following product segments: Kits & consumables, Instruments and Services. More than 90% of liquid biopsy market is comprised by kits & Consumables and Instruments.
By Circulating Biomarkers
The report studies the liquid biopsy market by Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA) & Exosomes. Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA) together holds significant market share
By Sample – Plasma/Serum accounts for the maximum market
In terms of Sample used for liquid biopsy, the global liquid biopsy market has been studied as Plasma/Serum, Urine and Others.
By Clinical Application – Screening Purpose leads the Liquid Biopsy Market
The report studies the market of the following clinical application segments: Monitoring, Prognosis, Theranostics & Screening.
By Region – North America and Europe will drive the Liquid Biopsy Market
North America and Europe together controls the Liquid Biopsy Market. In addition; the report also provides the complete geographical analysis of Asia-Pacific, Latin America and Middle East/Africa Liquid Biopsy Market.
Companies Analysis
Thermo Fisher Scientific Inc., Roche Diagnostics, Bio-Rad Laboratories Inc., Biocept Inc., Biocartis, Myriad Genetics, Inc., Genomic Health, NeoGenomics Laboratories, Qiagen; which has been studied thoroughly in the report.
All the 9 Companies Studied in the Report have been Studied from 3 Points
• Company Overview
• Product Portfolio
• Financial Insight
This market research report provides a complete analysis of the Liquid Biopsy Market, Growth Drivers, Challenges, and their projections for the upcoming years.
By Cancer
• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Prostate Cancer
• Others
By Product
• Kits & Consumables
• Instruments
• Services
By Circulating Biomarkers
• Circulating Tumor Cells (CTCs)
• Circulating Tumor DNA (ctDNA)
• Exosomes
By Sample
• Plasma/Serum
• Urine
• Others
By Clinical Application
• Monitoring
• Prognosis
• Theranostics
• Screening
By Regions
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East/Africa
By Companies
• Thermo Fisher Scientific Inc.
• Roche Diagnostics
• Bio-Rad Laboratories Inc.
• Biocept Inc.
• Biocartis
• Myriad Genetics, Inc.
• Genomic Health
• NeoGenomics Laboratories
• Qiagen
Contact Us
Rajat Gupta
Sr. Marketing Manager
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com
Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets.
225 Kristie Ln, Roswell, GA 30076, United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liquid Biopsy Market is projected US$ 3.4 Billion by 2024 here
News-ID: 1160610 • Views: …
More Releases from Renub Research
Lung Cancer Diagnostics Market, Size, Global Forecast, Industry Trends, Share, G …
Global lung cancer diagnostics market is projected to attain about US$ 30.84 billion through 2030, as per Renub Research
Lung cancers consequences from uncontrolled cell growth, forming loads referred to as tumors. Typically originating from the lining cells of the airlines (bronchi and bronchioles), it is frequently referred to as bronchogenic cancers or carcinoma. Cigarette smoking is the primary cause, contributing to approximately 90% of instances, at the same time…
Industrial Enzymes Market Surges Towards US$ 10.10 Billion by 2030, Indicates Ma …
Global Industrial Enzymes Market size is projected to be priced at around US$ 10.10 billion by 2030, according to Renub Research. Enzymes are proteins that catalyze chemical reactions. As such, enzymes have been widely used to facilitate industrial processes and the production of products, and these enzymes are referred to as industrial enzymes. Although it dates back to ancient times when enzymes were used in baking, brewing, cheese making, etc.,…
Global Cosmetics Market: Explosive Growth Anticipated with 532% CAGR Forecast fr …
Renub Research predicts the cosmetics market will reach US$ 498.05 Billion by 2032. The cosmetics enterprise has grown to be an important a part of human beings' daily lifestyles, and social media advertising has end up a widespread strategy for diverse organizations within the market to growth buyer attain. The rise in internet penetration and social media customers presents a possibility for cosmetics organizations to promote their services and products…
Autoimmune Disease Diagnostics Market Hits US$5.32 Billion in 2023, Anticipated …
Global Autoimmune Disease Diagnostics market is projected to be valued at around US$ 8.64 Billion by 2030, as per Renub Research. Autoimmune disease diagnostics normally contain a combination of blood markers, specific signs, and sometimes a tissue biopsy. Autoimmune disorders broaden whilst the immune device attacks its cells due to abnormalities. The failure to detect immune cells, tissues, & organs and produce autoantibodies targeting these cells reasons the immune system…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview
Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports.
This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top…
